Castle Biosciences (CSTL) Debt Ratio (2018 - 2026)

Castle Biosciences has reported Debt Ratio for 7 years, with the latest figure at 0.02 in Q2 2026.

• Quarterly Debt Ratio rose 5.23% year-over-year to 0.02 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.02 (up 5.23% YoY) and the FY2025 annual result came in at 0.02, down 6.64% from the prior year.
• Debt Ratio improved to 0.02 in Q2 2026 per CSTL's latest filing, from 0.02 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.05 in Q1 2022 and troughed at 0.02 in Q3 2025.
• A 4-year average of 0.02 and a median of 0.02 in 2026 frame the typical range for Debt Ratio.
• The widest YoY moves for Debt Ratio: up 7.12% in 2025, down 8.26% in 2025.
• Over 4 years, Debt Ratio stood at 0.05 in 2022, then sank by 58.67% to 0.02 in 2024, then decreased by 6.64% to 0.02 in 2025, then climbed by 27.88% to 0.02 in 2026.
• According to Business Quant data, Debt Ratio over the past three periods registered 0.02, 0.02, and 0.02 for Q2 2026, Q1 2026, and Q4 2025 respectively.